Trump Admin. to Investigate School Over Claim That a Trans Wrestler Assaulted a...
Leave It to Leavitt: CNN’s Kaitlan Collins Says 'Fascist' Press Secretary Defended Her...
They've Gone and Done It AGAIN: Abi Spanberger's Grilling Photo Op Is Peak...
A Different Arena: Sportscaster Stephen A. Smith Looks to Shake Up the DNC’s...
INVASION! One Simple Graph Demonstrates How Dems Tried to Destroy America With Illegal...
Defiant Don Lemon Pleads ‘Not Guilty’ to Violating Congregants’ Rights in Minnesota Church...
Spartacus Is SHOCKED! Cory Booker Feigns Outrage When Called Out on Dems' Immigration...
BRO, That's NOT How It Works: Jessica Reidl's Tantrum Over Women's Birth Certificates...
Trump Stuns Democrats, 2026 Panic As Republicans Surge?
*SNORT* Lt. Gov Peggy Flanagan Shares Her 'Tribe Name' and LOL Its Meaning...
US Oil and Gas Assn. Notices They're a Useful Prop for Democrat Photo...
Free Stuff Isn't FREE? WHO KNEW?! Zohran Mamdani Reverses Course on Yet ANOTHER...
NBC News Baffled That Most Latinos Do Not Use The Term 'Latinx'
ABC News Reports This Inflation Update Is 'Defying Fears' (Stoked by Dems and...
WHOA. Bad Timing?! Pramila Jayapal Shares Her Shiny New Trans Bill of Rights...

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement